Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Breast Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Not applicableWithdrawnNCT06057636
What this trial is testing

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Who this might be right for
Breast CancerInflammatory Breast Cancer Stage IVInflammatory Breast Neoplasms+2 more
The University of Tennessee, Knoxville
Early research (Phase 1)UnknownNCT00002616
What this trial is testing

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Illinois at Chicago 36
Testing effectiveness (Phase 2)Ended earlyNCT02658812
What this trial is testing

Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Malignant Chest Wall NeoplasmRecurrent Breast CarcinomaRecurrent Inflammatory Breast Carcinoma+2 more
M.D. Anderson Cancer Center 11
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Not applicableStudy completedNCT00756132
What this trial is testing

Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca

Who this might be right for
Locally Advanced Breast CancerBreast Cancer
University Health Network, Toronto 120
Testing effectiveness (Phase 2)Ended earlyNCT02892734
What this trial is testing

Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer

Who this might be right for
HER2/Neu NegativeRecurrent Inflammatory Breast CarcinomaStage IV Breast Cancer+1 more
Northwestern University 3
Not applicableUnknownNCT00336089
What this trial is testing

Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors

Who this might be right for
Breast CancerCancer SurvivorFatigue+1 more
Clayton State University 54
Testing effectiveness (Phase 2)Ended earlyNCT01938833
What this trial is testing

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Who this might be right for
HER2-negative Breast CancerInflammatory Breast CancerMale Breast Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Not applicableStudy completedNCT01048918
What this trial is testing

Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer

Who this might be right for
Locally Advanced Breast CancerMetastatic (Stage IV) Breast CancerStage III-IV Breast Cancer or Inflammatory
City of Hope Medical Center 280
Large-scale testing (Phase 3)Study completedNCT01426880
What this trial is testing

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 595
Testing effectiveness (Phase 2)Study completedNCT00003199
What this trial is testing

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more
Fred Hutchinson Cancer Center 50
Early research (Phase 1)Study completedNCT00005822
What this trial is testing

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 21
Not applicableUnknownNCT00094133
What this trial is testing

Hypnosis in Treating Hot Flashes in Breast Cancer Survivors

Who this might be right for
Breast CancerCancer SurvivorHot Flashes
Scott and White Hospital & Clinic 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03202316
What this trial is testing

Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

Who this might be right for
Recurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT05243641
What this trial is testing

Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test

Who this might be right for
Metastatic Breast CancerBreast Cancer
M.D. Anderson Cancer Center 10
Very early researchStudy completedNCT01881048
What this trial is testing

Window of Opportunity Study Targeting the Inflammatory Milieu

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage II Breast Cancer+4 more
University of Colorado, Denver 42
Not applicableStudy completedNCT00033397
What this trial is testing

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 360
Testing effectiveness (Phase 2)Ended earlyNCT05041101
What this trial is testing

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaRecurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 6
Next Page